Skip to main content
. Author manuscript; available in PMC: 2010 Jul 21.
Published in final edited form as: Cancer Ther. 2009 Apr 14;7(A):254–267.

Table 2.

Targeted deletion of inflammatory chemokineand chemokinereceptors in mice

Gene phenotype citation
CCL2 diminished macrophage and TH1 T cell responses inexperimental autoimmune encephalomyelitis (EAE), no compensatory upregulation of CCR2 binding ligands Huang et al, 2001
CCR2 decreased formation of lung granulomas induced by mycobacterium bovis, similar phenotype in EAE as ccl2-/-, decreased monocyte recruitment to inflamed tissues Boring et al, 1997; Fife et al, 2000; Tsou et al, 2007
CCL5 defects in T cell proliferation, an overall reduction in T cell activation and recruitment in cutaneous delayed-type hypersensitivity assays Makino et al, 2002
CCR5 decreased NK cell mobilization in mice infected with herpes simplex virus 2 leading to decreased survival, increased NK cell infiltration in experimental mouse model of colitis correlating with increased resistance to disease Yamaoka et al, 1998; Andres et al, 2000; Thapa et al, 2007
CXCL1 artherosclerotic lesions leads to a reduction in macrophage recruitment associated with decreased lesion formation Boisvert et al, 2006
CXCR2 decreased neutrophil recruitment and delayed wound healing responses, abnormal granulocyte differentiation, mice develop splenomegaly Cacalano et al, 1994; Devalaraja et al, 2000
CXCL12 perinatal lethality, defects in B cell development in in fetal liver and bone marrow, reduction in myeloid progenitors in bone marrow, defects in cardiac development Nagasawa et al, 1996
CXCR4 perinatal lethality due to multiple defects including decreased bone marrow cell and B cell development abnormal cerebellum morphology Ma et al, 1998